Page last updated: 2024-12-07

4-methoxymethylpyridoxine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-methoxymethylpyridoxine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID76581
CHEMBL ID1076875
CHEBI ID166575
SCHEMBL ID9127650
MeSH IDM0042037

Synonyms (39)

Synonym
BB 0261944
5-(hydroxymethyl)-4-(methoxymethyl)-2-methylpyridin-3-ol
ginkgotoxin
CHEBI:166575
5-(hydroxymethyl)-4-(methoxymethyl)-2-methyl-pyridin-3-ol
3-pyridinemethanol, 5-hydroxy-4-(methoxymethyl)-6-methyl-
4-o-methoxypyridoxine
1464-33-1
5-hydroxy-4-(methoxymethyl)-6-methyl-3-pyridinemethanol
alpha(sup 4)-o-methylpyridoxol
4-methoxypyridoxine
4-methoxymethylpyridoxine
brn 0150788
CHEMBL1076875
5-hydroxymethyl-4-methoxymethyl-2-methyl-pyridin-3-ol
A3196
AKOS006272520
3-hydroxy-5-hydroxymethyl-4-methoxymethyl-2-methylpyridine
bsn7f3yj95 ,
5-21-05-00494 (beilstein handbook reference)
unii-bsn7f3yj95
FT-0682272
gt0 ,
4EN4
SVINQHQHARVZFF-UHFFFAOYSA-N
.alpha.(sup 4)-o-methylpyridoxol
SCHEMBL9127650
DTXSID00163366
ginkgotoxin, analytical standard
5-hydroxy-4-(methoxymethyl)-6-methyl-3-pyridinemethanol, 9ci
4'-methoxypyridoxine
4-o-methylpyridoxine (ginkgotoxin)
Q5563158
4'-o-methylpyridoxine
MS-22979
E88579
CS-0140215
HY-N8157
alpha4-o-methylpyridoxol

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" Knowledge about the pharmacokinetic behaviour of these substances is necessary to discuss the pharmacological results on a more realistic basis."( Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients.
Schubert-Zsilavecz, M; Ude, C; Wurglics, M, 2013
)
0.39
" The proposed method is selective, precise and accurate enough of MPN and its metabolites (4-pyridoxic Acid, pyridoxal, and pyridoxine) for the pharmacokinetic study."( Interactions of pharmacokinetic profiles of Ginkgotoxin and Ginkgolic acids in rat plasma after oral administration.
Duan, JA; Guo, S; Qian, D; Qian, Y; Su, S; Tao, J; Wei, M; Yan, H; Zhu, Z, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
pyridinesAny organonitrogen heterocyclic compound based on a pyridine skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Pyridoxal kinaseHomo sapiens (human)Ki3.00003.000026.500050.0000AID977610
Chain A, Pyridoxal KinaseHomo sapiens (human)Ki3.00003.000026.500050.0000AID977610
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Pyridoxal kinaseHomo sapiens (human)Km5.00005.00007.45009.9000AID464423
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (3)

Processvia Protein(s)Taxonomy
pyridoxal 5'-phosphate salvagePyridoxal kinaseHomo sapiens (human)
pyridoxal metabolic processPyridoxal kinaseHomo sapiens (human)
pyridoxamine metabolic processPyridoxal kinaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (9)

Processvia Protein(s)Taxonomy
magnesium ion bindingPyridoxal kinaseHomo sapiens (human)
ATP bindingPyridoxal kinaseHomo sapiens (human)
zinc ion bindingPyridoxal kinaseHomo sapiens (human)
pyridoxal kinase activityPyridoxal kinaseHomo sapiens (human)
pyridoxal phosphate bindingPyridoxal kinaseHomo sapiens (human)
potassium ion bindingPyridoxal kinaseHomo sapiens (human)
sodium ion bindingPyridoxal kinaseHomo sapiens (human)
lithium ion bindingPyridoxal kinaseHomo sapiens (human)
protein homodimerization activityPyridoxal kinaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (7)

Processvia Protein(s)Taxonomy
extracellular regionPyridoxal kinaseHomo sapiens (human)
nucleusPyridoxal kinaseHomo sapiens (human)
nucleoplasmPyridoxal kinaseHomo sapiens (human)
cytosolPyridoxal kinaseHomo sapiens (human)
secretory granule lumenPyridoxal kinaseHomo sapiens (human)
specific granule lumenPyridoxal kinaseHomo sapiens (human)
extracellular exosomePyridoxal kinaseHomo sapiens (human)
cytosolPyridoxal kinaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID464431Plasma concentration in human with epileptic convulsions2010Journal of natural products, Jan, Volume: 73, Issue:1
Ginkgo biloba and ginkgotoxin.
AID464430Toxicity in ip dosed rabbit2010Journal of natural products, Jan, Volume: 73, Issue:1
Ginkgo biloba and ginkgotoxin.
AID464424Lipophilicity, log P of the compound2010Journal of natural products, Jan, Volume: 73, Issue:1
Ginkgo biloba and ginkgotoxin.
AID464429Toxicity in rat assessed as induction of convulsions at 400 to 600 mg/kg, ip 2010Journal of natural products, Jan, Volume: 73, Issue:1
Ginkgo biloba and ginkgotoxin.
AID464427Toxicity in guinea pig assessed as induction of seizures at 11 mg/kg 2010Journal of natural products, Jan, Volume: 73, Issue:1
Ginkgo biloba and ginkgotoxin.
AID464428Drug level in human plasma 58.6 ug QD2010Journal of natural products, Jan, Volume: 73, Issue:1
Ginkgo biloba and ginkgotoxin.
AID464425Inhibition of human brain Gad65 expressed in Escherichia coli at 2.7 mM2010Journal of natural products, Jan, Volume: 73, Issue:1
Ginkgo biloba and ginkgotoxin.
AID464423Activity at human PKH kinase expressed in Escherichia coli by affinity chromatography2010Journal of natural products, Jan, Volume: 73, Issue:1
Ginkgo biloba and ginkgotoxin.
AID464426Inhibition of human Gad672010Journal of natural products, Jan, Volume: 73, Issue:1
Ginkgo biloba and ginkgotoxin.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2012PloS one, , Volume: 7, Issue:7
Crystal structures of human pyridoxal kinase in complex with the neurotoxins, ginkgotoxin and theophylline: insights into pyridoxal kinase inhibition.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (46)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (23.91)18.7374
1990's3 (6.52)18.2507
2000's11 (23.91)29.6817
2010's14 (30.43)24.3611
2020's7 (15.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.89

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.89 (24.57)
Research Supply Index3.89 (2.92)
Research Growth Index4.78 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.89)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (12.50%)6.00%
Case Studies6 (12.50%)4.05%
Observational0 (0.00%)0.25%
Other36 (75.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]